Archives for October 2008
The FDA has approved ATS Medical’s 3f Aortic Bioprosthesis (3fAB), a poorly named, but potentially revolutionary pericardial aortic tissue valve.
3fAB’s blood flow dynamics and improved stress distribution mimic the functional characteristics of the native valve, […]
31 October 2008 |
Blog, news1, feature2 |
Third quarter revenues at Clarient increased 59% to $19.0 million from the $11.9 million reported in Q3 2007. This marks the company’s 17th consecutive quarter of sequential revenue growth. Higher testing volume, a favorable service […]
30 October 2008 |
Blog, Member Spotlight, news2 |
When an athlete is injured, their career and value to the team are at risk. At all levels of athletics, including everyday fitness enthusiasts, the frequency and severity of injuries makes it imperative to find […]
29 October 2008 |
Blog, news2, Video |
Quarterly revenues at Cynosure, a developer of laser-based aesthetic systems, grew 21% year-over-year, from $31.5 million in Q3 2007 to $38.2 million in the most recent quarter. Second quarter revenues were $39.2 million.
Net income for […]
28 October 2008 |
Blog, news1, feature1 |
Only months after Langer sold its Bi-Op subsidiary for less than its purchase price, the company announced the sale of its custom orthotics business to The Orthotic Group (TOG), a manufacturer of prescription custom foot […]
27 October 2008 |
Blog, news2, feature2 |
Endologix, developer of a treatment for abdominal aortic aneurysms (AAA), saw revenues increase 42% in its third quarter. The company reported $9.4 million in sales and expects “at least” $10 million in fourth quarter revenue. […]
24 October 2008 |
Blog, news1, feature2 |
First Quarter Results:
Revenues at Candela Corporation, a maker of aesthetic lasers, decreased 24 percent year-over-year, to $26.9 million in the most recent quarter from $35.5 million last year. The decrease in revenues took its toll […]
23 October 2008 |
Blog, news1, feature1 |
22 October 2008 |
ad1 |
More good news from Endologix, the Irvine, CA-based company mulling over a $98 million buyout bid from hedge fund Elliott Associates.
This week, the company’s IntuiTrak Delivery System was approved by the FDA. The System will […]
22 October 2008 |
Blog, news1 |
NxStage Medical has signed a long-term product supply agreement with Renal Advantage (RAI), the fourth largest provider of dialysis services in the U.S. Under the terms of the agreement, NxStage will supply the Streamline airless […]
21 October 2008 |
Blog, news1 |
